Clinical trials
Completed Pathologic Complete Response trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
42 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 5 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 42 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 2 |
| M.D. Anderson Cancer Center | 2 |
| Sixth Affiliated Hospital, Sun Yat-sen University | 2 |
| 307 Hospital of PLA | 1 |
| Asociación para el Progreso de la Oncología en Málaga | 1 |
| BioFire Diagnostics, LLC | 1 |
| Celgene | 1 |
| Centre Hospitalier Universitaire de Nīmes | 1 |
| Doc Lab Inc | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pathologic Complete Response | 42 |
| Rectal Neoplasms | 7 |
| Leukemia, Myeloid, Acute | 5 |
| Breast Neoplasms | 4 |
| Leukemia | 3 |
| Neoplasm Metastasis | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Aspergillosis | 1 |
| COVID-19 | 1 |
| Candidiasis | 1 |
Trials
Showing 76 to 42 of 42. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.